Anees Bahji1, Breagh Cheng, Samantha Gray, Heather Stuart. 1. Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada (AB, BC, SG, HS); Department of Psychiatry, Queen's University, Kingston, Ontario, Canada (AB).
Abstract
BACKGROUND AND AIMS: Opioids are among the most commonly used class of illicit drugs. We aimed to produce pooled estimates of mortality risks among people with opioid use disorder (OUD), with a focus upon all-cause mortality, and also overdose-specific causes of death. DESIGN: Systematic review and meta-analysis of cohorts of people with OUD involving illicit opioids with data on all-cause or overdose-specific mortality. SETTING AND PARTICIPANTS: Of 4247 papers, 92 were eligible, reporting on 101 cohorts that measured all-cause mortality and opioid-overdose mortality. Cohorts (n = 101-229,274) were in North America, Australia, several Eastern and Western European countries, and Asia. MEASUREMENT: Titles/abstracts and full texts were independently screened by 2 reviewers, with discrepancies resolved via a third reviewer. We extracted data on crude mortality rates (CMRs) per 1000 person-years (PY); we imputed CMRs where possible if not reported by study authors. We also calculated mortality relative risks. Data were pooled using random-effects models; potential reasons for heterogeneity were explored using subgroup analyses and meta-regressions. FINDINGS: The overall all-cause CMR was 18.7 per 1000 PY (95% confidence interval [CI] 17.1-20.3). The overall overdose-specific CMR was 7.0 per 1000 PY (95% CI 6.1-8.0). All-cause and overdose-specific mortality were substantially higher in low/middle-income countries, among those with HIV, and among people who use injection drugs. CONCLUSIONS: Individuals with OUD carry a high risk of all-cause and overdose-specific mortality. Potentially modifiable risk factors, such as HIV and injection drug use, were predictive of mortality risk and are amenable to global efforts aiming to improve access to OUD treatment and targeted harm reduction efforts.
BACKGROUND AND AIMS: Opioids are among the most commonly used class of illicit drugs. We aimed to produce pooled estimates of mortality risks among people with opioid use disorder (OUD), with a focus upon all-cause mortality, and also overdose-specific causes of death. DESIGN: Systematic review and meta-analysis of cohorts of people with OUD involving illicit opioids with data on all-cause or overdose-specific mortality. SETTING AND PARTICIPANTS: Of 4247 papers, 92 were eligible, reporting on 101 cohorts that measured all-cause mortality and opioid-overdose mortality. Cohorts (n = 101-229,274) were in North America, Australia, several Eastern and Western European countries, and Asia. MEASUREMENT: Titles/abstracts and full texts were independently screened by 2 reviewers, with discrepancies resolved via a third reviewer. We extracted data on crude mortality rates (CMRs) per 1000 person-years (PY); we imputed CMRs where possible if not reported by study authors. We also calculated mortality relative risks. Data were pooled using random-effects models; potential reasons for heterogeneity were explored using subgroup analyses and meta-regressions. FINDINGS: The overall all-cause CMR was 18.7 per 1000 PY (95% confidence interval [CI] 17.1-20.3). The overall overdose-specific CMR was 7.0 per 1000 PY (95% CI 6.1-8.0). All-cause and overdose-specific mortality were substantially higher in low/middle-income countries, among those with HIV, and among people who use injection drugs. CONCLUSIONS: Individuals with OUD carry a high risk of all-cause and overdose-specific mortality. Potentially modifiable risk factors, such as HIV and injection drug use, were predictive of mortality risk and are amenable to global efforts aiming to improve access to OUD treatment and targeted harm reduction efforts.